Gilead Sciences Announces Second Quarter 2020 Dividend

FOSTER CITY, Calif.--(BUSINESS WIRE)-- Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the company’s Board of Directors has declared a cash dividend of $0.68 per share of common stock for the second quarter of 2020. The dividend is payable on June 29, 2020, to stockholders of record at the close of business on June 12, 2020. Future dividends will be subject to Board approval.

About Gilead Sciences

Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The company strives to transform and simplify care for people with life-threatening illnesses around the world. Gilead has operations in more than 35 countries worldwide, with headquarters in Foster City, California.

For more information on Gilead Sciences, please visit the company’s website at www.gilead.com, follow Gilead on Twitter (@GileadSciences) or call Gilead Public Affairs at 1-800-GILEAD-5 or 1-650-574-3000.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200430005860/en/

Investors
Andrew Dickinson
(650) 524-0862

Douglas Maffei, Ph.D.
(650) 522-2739

Source: Gilead Sciences, Inc.

You May Also Be Interested In

• EU approves Gilead's Trodelvy for first-line metastatic TNBC
• DSM and LEO Stockholders Vote to Support Board Nominees in Certified Results of 2026 Annual Stockholder Meetings
• Alphabet Set to Join and Honeywell International to Remain in Dow Jones Industrial Average